248 related articles for article (PubMed ID: 21169249)
1. Evaluating patient-centered outcomes in the randomized controlled trial and beyond: informing the future with lessons from the past.
Booth CM
Clin Cancer Res; 2010 Dec; 16(24):5963-71. PubMed ID: 21169249
[TBL] [Abstract][Full Text] [Related]
2. Making the investigational oncology pipeline more efficient and effective: are we headed in the right direction?
LoRusso PM; Anderson AB; Boerner SA; Averbuch SD
Clin Cancer Res; 2010 Dec; 16(24):5956-62. PubMed ID: 21169248
[TBL] [Abstract][Full Text] [Related]
3. Using routine data to complement and enhance the results of randomised controlled trials.
Lewsey JD; Leyland AH; Murray GD; Boddy FA
Health Technol Assess; 2000; 4(22):1-55. PubMed ID: 11074392
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial design in systemic lupus erythematosus.
Dall'Era M; Wofsy D
Curr Opin Rheumatol; 2006 Sep; 18(5):476-80. PubMed ID: 16896285
[TBL] [Abstract][Full Text] [Related]
5. A new 'mechanistic-practical" framework for designing and interpreting randomized trials.
Karanicolas PJ; Montori VM; Devereaux PJ; Schünemann H; Guyatt GH
J Clin Epidemiol; 2009 May; 62(5):479-84. PubMed ID: 18468856
[TBL] [Abstract][Full Text] [Related]
6. Appropriately selecting and concisely reporting the outcome measures of randomized controlled trials of traditional Chinese medicine.
Bian ZX; Moher D; Li YP; Wu TX; Dagenais S; Cheng CW; Li J; Li TQ
Zhong Xi Yi Jie He Xue Bao; 2008 Aug; 6(8):771-5. PubMed ID: 18664342
[TBL] [Abstract][Full Text] [Related]
7. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trials: the meeting place of medical practice and clinical research.
Hughes EG
Semin Reprod Med; 2003 Feb; 21(1):55-64. PubMed ID: 12806560
[TBL] [Abstract][Full Text] [Related]
9. Redefining the randomized controlled trial in the context of acupuncture research.
Walji R; Boon H
Complement Ther Clin Pract; 2006 May; 12(2):91-6. PubMed ID: 16648085
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness as an outcome in randomized clinical trials.
Hlatky MA; Owens DK; Sanders GD
Clin Trials; 2006; 3(6):543-51. PubMed ID: 17170039
[TBL] [Abstract][Full Text] [Related]
11. The randomized controlled trial.
Stel VS; Zoccali C; Dekker FW; Jager KJ
Nephron Clin Pract; 2009; 113(4):c337-42. PubMed ID: 19752576
[TBL] [Abstract][Full Text] [Related]
12. Evolution of the randomized controlled trial in oncology over three decades.
Booth CM; Cescon DW; Wang L; Tannock IF; Krzyzanowska MK
J Clin Oncol; 2008 Nov; 26(33):5458-64. PubMed ID: 18955452
[TBL] [Abstract][Full Text] [Related]
13. Lessons learned combining N-of-1 trials to assess fibromyalgia therapies.
Zucker DR; Ruthazer R; Schmid CH; Feuer JM; Fischer PA; Kieval RI; Mogavero N; Rapoport RJ; Selker HP; Stotsky SA; Winston E; Goldenberg DL
J Rheumatol; 2006 Oct; 33(10):2069-77. PubMed ID: 17014022
[TBL] [Abstract][Full Text] [Related]
14. How to read a report of a randomized controlled trial.
Jun M; Zoungas S; Perkovic V; Webster AC
Nephrology (Carlton); 2010 Mar; 15(2):153-7. PubMed ID: 20470272
[TBL] [Abstract][Full Text] [Related]
15. Design and endpoints of clinical trials in hepatocellular carcinoma.
Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
[TBL] [Abstract][Full Text] [Related]
16. Reading the research literature. Putting randomized clinical trials into practice. 2.
Riegelman R
Md Med; 2002; 3(2):52-6. PubMed ID: 12056230
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care.
Meyers FJ; Linder J; Beckett L; Christensen S; Blais J; Gandara DR
J Pain Symptom Manage; 2004 Dec; 28(6):548-56. PubMed ID: 15589080
[TBL] [Abstract][Full Text] [Related]
18. Is proper methodology associated with the use of a clinically relevant outcome measure? The case of randomized clinical trials on medical treatment of open-angle glaucoma.
Rossetti L; Marchetti I; Orzalesi N; Scorpiglione N; Liberati A
Online J Curr Clin Trials; 1993 Nov; Doc No 100():[6512 words; 199 paragraphs]. PubMed ID: 8305993
[TBL] [Abstract][Full Text] [Related]
19. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
Carroll KJ
Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
[TBL] [Abstract][Full Text] [Related]
20. Outcome measures in immune-mediated neuropathies: the need to standardize their use and to understand the clinimetric essentials.
van Nes SI; Faber CG; Merkies IS
J Peripher Nerv Syst; 2008 Jun; 13(2):136-47. PubMed ID: 18601658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
